POZEN Inc. (POZN: Quote), a pharmaceutical company, said the United States Patent and Trademark Office has issued to POZEN U.S. Patent 8,206,741 titled 'Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs'. This patent comprises claims to pharmaceutical compositions containing aspirin and a proton pump inhibitor or PPI.
POZEN's PA combination drug candidates are covered under this patent. The '741 patent is the second U.S. patent issued to POZEN for the coordinated delivery of NSAIDs, but the first in which the claims are focused on aspirin-based products.
Click here to receive FREE breaking news email alerts for POZEN Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org